Studies have revealed that TRIM14 can enhance chemoresistance, malignancy, and invasion of glioma cells by modulating the Wnt/β-catenin signaling pathway [59], p38/MAPK pathway [60], and zinc finger E-box binding homeobox 2 [61]. This evidence concerns the gene TRIM14 and central nervous system cancer.